Re: Seroquel diabetes payout = $11,000 = about £7,000

[Guest guest]

According to Bloomberg the payouts would average about $11,000 per litigant. An attorney familiar with the case and the mediation said that a return to court-ordered mediation would not necessarily improve the chances that the parties would settle at that umber.

>> > > > Seroquel Maker Given More Time to Settle Lawsuits> > > > September 14, 2010. By Gordon Gibb> /> London, UK/: AstraZeneca, the manufacturer of /Seroquel/ > <http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>, > has been granted more time to settle nearly 6,000 lawsuits. The lawsuits > at issue are only a portion of some 17,500 lawsuits that the > manufacturer has agreed to settle by way of a $198 million kitty. That > announcement was made last month.> > However, the 6,000 will have to wait a little longer after the US > Judicial Panel on Multidistrict Litigation vacated orders to send the > cases back to their home courts for trial in late August. The cases, > consolidated in federal court in Florida, according to /Bloomberg > BusinessWeek/ on 10/01/10, could suffer undue hindrance in arriving at > settlements.> > "A remand at this juncture would likely disrupt the settlement dialog," > US District Judge Anne Conway, based in Orlando, Florida, said in an > August 30 order asking the judicial panel to forgo remands. Returning > the cases could "stall negotiations altogether," Conway said.> > AstraZeneca, the UK's second-largest drug manufacturer, faces a total of > 26,000 lawsuits alleging various Seroquel side effects, including birth > defects. The manufacturer has settled about two thirds of those cases.> > "We remain committed to a strong defense effort, but will continue to > participate in the court-ordered mediation process," Tony Jewell, a US > spokesman for the drug maker, said in an interview on August 31.> > According to /Bloomberg/ the payouts would average about $11,000 per > litigant. An attorney familiar with the case and the mediation said that > a return to court-ordered mediation would not necessarily improve the > chances that the parties would settle at that umber. He said that while > he would continue to participate in the mediation process, he believes > that at that figure the cases would not settle.> > Seroquel, which has also been allegedly linked to hyperglycemia and > tardive dyskinesia, is the second-largest selling drug in AstraZeneca's > basket of products, achieving $4.9 billion in sales last year, according > to /Bloomberg/.>

[Guest guest]

According to Bloomberg the payouts would average about $11,000 per litigant. An attorney familiar with the case and the mediation said that a return to court-ordered mediation would not necessarily improve the chances that the parties would settle at that umber.

>> > > > Seroquel Maker Given More Time to Settle Lawsuits> > > > September 14, 2010. By Gordon Gibb> /> London, UK/: AstraZeneca, the manufacturer of /Seroquel/ > <http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>, > has been granted more time to settle nearly 6,000 lawsuits. The lawsuits > at issue are only a portion of some 17,500 lawsuits that the > manufacturer has agreed to settle by way of a $198 million kitty. That > announcement was made last month.> > However, the 6,000 will have to wait a little longer after the US > Judicial Panel on Multidistrict Litigation vacated orders to send the > cases back to their home courts for trial in late August. The cases, > consolidated in federal court in Florida, according to /Bloomberg > BusinessWeek/ on 10/01/10, could suffer undue hindrance in arriving at > settlements.> > "A remand at this juncture would likely disrupt the settlement dialog," > US District Judge Anne Conway, based in Orlando, Florida, said in an > August 30 order asking the judicial panel to forgo remands. Returning > the cases could "stall negotiations altogether," Conway said.> > AstraZeneca, the UK's second-largest drug manufacturer, faces a total of > 26,000 lawsuits alleging various Seroquel side effects, including birth > defects. The manufacturer has settled about two thirds of those cases.> > "We remain committed to a strong defense effort, but will continue to > participate in the court-ordered mediation process," Tony Jewell, a US > spokesman for the drug maker, said in an interview on August 31.> > According to /Bloomberg/ the payouts would average about $11,000 per > litigant. An attorney familiar with the case and the mediation said that > a return to court-ordered mediation would not necessarily improve the > chances that the parties would settle at that umber. He said that while > he would continue to participate in the mediation process, he believes > that at that figure the cases would not settle.> > Seroquel, which has also been allegedly linked to hyperglycemia and > tardive dyskinesia, is the second-largest selling drug in AstraZeneca's > basket of products, achieving $4.9 billion in sales last year, according > to /Bloomberg/.>

[Guest guest]

According to Bloomberg the payouts would average about $11,000 per litigant. An attorney familiar with the case and the mediation said that a return to court-ordered mediation would not necessarily improve the chances that the parties would settle at that umber.

>> > > > Seroquel Maker Given More Time to Settle Lawsuits> > > > September 14, 2010. By Gordon Gibb> /> London, UK/: AstraZeneca, the manufacturer of /Seroquel/ > <http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>, > has been granted more time to settle nearly 6,000 lawsuits. The lawsuits > at issue are only a portion of some 17,500 lawsuits that the > manufacturer has agreed to settle by way of a $198 million kitty. That > announcement was made last month.> > However, the 6,000 will have to wait a little longer after the US > Judicial Panel on Multidistrict Litigation vacated orders to send the > cases back to their home courts for trial in late August. The cases, > consolidated in federal court in Florida, according to /Bloomberg > BusinessWeek/ on 10/01/10, could suffer undue hindrance in arriving at > settlements.> > "A remand at this juncture would likely disrupt the settlement dialog," > US District Judge Anne Conway, based in Orlando, Florida, said in an > August 30 order asking the judicial panel to forgo remands. Returning > the cases could "stall negotiations altogether," Conway said.> > AstraZeneca, the UK's second-largest drug manufacturer, faces a total of > 26,000 lawsuits alleging various Seroquel side effects, including birth > defects. The manufacturer has settled about two thirds of those cases.> > "We remain committed to a strong defense effort, but will continue to > participate in the court-ordered mediation process," Tony Jewell, a US > spokesman for the drug maker, said in an interview on August 31.> > According to /Bloomberg/ the payouts would average about $11,000 per > litigant. An attorney familiar with the case and the mediation said that > a return to court-ordered mediation would not necessarily improve the > chances that the parties would settle at that umber. He said that while > he would continue to participate in the mediation process, he believes > that at that figure the cases would not settle.> > Seroquel, which has also been allegedly linked to hyperglycemia and > tardive dyskinesia, is the second-largest selling drug in AstraZeneca's > basket of products, achieving $4.9 billion in sales last year, according > to /Bloomberg/.>

[Guest guest]

According to Bloomberg the payouts would average about $11,000 per litigant. An attorney familiar with the case and the mediation said that a return to court-ordered mediation would not necessarily improve the chances that the parties would settle at that umber.

>> > > > Seroquel Maker Given More Time to Settle Lawsuits> > > > September 14, 2010. By Gordon Gibb> /> London, UK/: AstraZeneca, the manufacturer of /Seroquel/ > <http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>, > has been granted more time to settle nearly 6,000 lawsuits. The lawsuits > at issue are only a portion of some 17,500 lawsuits that the > manufacturer has agreed to settle by way of a $198 million kitty. That > announcement was made last month.> > However, the 6,000 will have to wait a little longer after the US > Judicial Panel on Multidistrict Litigation vacated orders to send the > cases back to their home courts for trial in late August. The cases, > consolidated in federal court in Florida, according to /Bloomberg > BusinessWeek/ on 10/01/10, could suffer undue hindrance in arriving at > settlements.> > "A remand at this juncture would likely disrupt the settlement dialog," > US District Judge Anne Conway, based in Orlando, Florida, said in an > August 30 order asking the judicial panel to forgo remands. Returning > the cases could "stall negotiations altogether," Conway said.> > AstraZeneca, the UK's second-largest drug manufacturer, faces a total of > 26,000 lawsuits alleging various Seroquel side effects, including birth > defects. The manufacturer has settled about two thirds of those cases.> > "We remain committed to a strong defense effort, but will continue to > participate in the court-ordered mediation process," Tony Jewell, a US > spokesman for the drug maker, said in an interview on August 31.> > According to /Bloomberg/ the payouts would average about $11,000 per > litigant. An attorney familiar with the case and the mediation said that > a return to court-ordered mediation would not necessarily improve the > chances that the parties would settle at that umber. He said that while > he would continue to participate in the mediation process, he believes > that at that figure the cases would not settle.> > Seroquel, which has also been allegedly linked to hyperglycemia and > tardive dyskinesia, is the second-largest selling drug in AstraZeneca's > basket of products, achieving $4.9 billion in sales last year, according > to /Bloomberg/.>

[Guest guest]

Can you post a link for that please? Thanks!

On 9/17/2010 2:34 PM, jeremy9282 wrote:

According to Bloomberg the payouts would average about $11,000

per litigant. An attorney familiar with the case and the

mediation said that a return to court-ordered mediation would

not necessarily improve the chances that the parties would

settle at that umber.

>

>

>

>

> Seroquel Maker Given More Time to Settle Lawsuits

>

>

>

> September 14, 2010. By Gordon Gibb

> /

> London, UK/: AstraZeneca, the manufacturer of /Seroquel/

>

<http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>,

> has been granted more time to settle nearly 6,000 lawsuits.

The lawsuits

> at issue are only a portion of some 17,500 lawsuits that

the

> manufacturer has agreed to settle by way of a $198 million

kitty. That

> announcement was made last month.

>

> However, the 6,000 will have to wait a little longer after

the US

> Judicial Panel on Multidistrict Litigation vacated orders

to send the

> cases back to their home courts for trial in late August.

The cases,

> consolidated in federal court in Florida, according to

/Bloomberg

> BusinessWeek/ on 10/01/10, could suffer undue hindrance in

arriving at

> settlements.

>

> "A remand at this juncture would likely disrupt the

settlement dialog,"

> US District Judge Anne Conway, based in Orlando, Florida,

said in an

> August 30 order asking the judicial panel to forgo remands.

Returning

> the cases could "stall negotiations altogether," Conway

said.

>

> AstraZeneca, the UK's second-largest drug manufacturer,

faces a total of

> 26,000 lawsuits alleging various Seroquel side effects,

including birth

> defects. The manufacturer has settled about two thirds of

those cases.

>

> "We remain committed to a strong defense effort, but will

continue to

> participate in the court-ordered mediation process," Tony

Jewell, a US

> spokesman for the drug maker, said in an interview on

August 31.

>

> According to /Bloomberg/ the payouts would average about

$11,000 per

> litigant. An attorney familiar wit! h the case and the

mediation said that

> a return to court-ordered mediation would not necessarily

improve the

> chances that the parties would settle at that umber. He

said that while

> he would continue to participate in the mediation process,

he believes

> that at that figure the cases would not settle.

>

> Seroquel, which has also been allegedly linked to

hyperglycemia and

> tardive dyskinesia, is the second-largest selling drug in

AstraZeneca's

> basket of products, achieving $4.9 billion in sales last

year, according

> to /Bloomberg/.

>

[Guest guest]

Can you post a link for that please? Thanks!

On 9/17/2010 2:34 PM, jeremy9282 wrote:

According to Bloomberg the payouts would average about $11,000

per litigant. An attorney familiar with the case and the

mediation said that a return to court-ordered mediation would

not necessarily improve the chances that the parties would

settle at that umber.

>

>

>

>

> Seroquel Maker Given More Time to Settle Lawsuits

>

>

>

> September 14, 2010. By Gordon Gibb

> /

> London, UK/: AstraZeneca, the manufacturer of /Seroquel/

>

<http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>,

> has been granted more time to settle nearly 6,000 lawsuits.

The lawsuits

> at issue are only a portion of some 17,500 lawsuits that

the

> manufacturer has agreed to settle by way of a $198 million

kitty. That

> announcement was made last month.

>

> However, the 6,000 will have to wait a little longer after

the US

> Judicial Panel on Multidistrict Litigation vacated orders

to send the

> cases back to their home courts for trial in late August.

The cases,

> consolidated in federal court in Florida, according to

/Bloomberg

> BusinessWeek/ on 10/01/10, could suffer undue hindrance in

arriving at

> settlements.

>

> "A remand at this juncture would likely disrupt the

settlement dialog,"

> US District Judge Anne Conway, based in Orlando, Florida,

said in an

> August 30 order asking the judicial panel to forgo remands.

Returning

> the cases could "stall negotiations altogether," Conway

said.

>

> AstraZeneca, the UK's second-largest drug manufacturer,

faces a total of

> 26,000 lawsuits alleging various Seroquel side effects,

including birth

> defects. The manufacturer has settled about two thirds of

those cases.

>

> "We remain committed to a strong defense effort, but will

continue to

> participate in the court-ordered mediation process," Tony

Jewell, a US

> spokesman for the drug maker, said in an interview on

August 31.

>

> According to /Bloomberg/ the payouts would average about

$11,000 per

> litigant. An attorney familiar wit! h the case and the

mediation said that

> a return to court-ordered mediation would not necessarily

improve the

> chances that the parties would settle at that umber. He

said that while

> he would continue to participate in the mediation process,

he believes

> that at that figure the cases would not settle.

>

> Seroquel, which has also been allegedly linked to

hyperglycemia and

> tardive dyskinesia, is the second-largest selling drug in

AstraZeneca's

> basket of products, achieving $4.9 billion in sales last

year, according

> to /Bloomberg/.

>

[Guest guest]

Can you post a link for that please? Thanks!

On 9/17/2010 2:34 PM, jeremy9282 wrote:

According to Bloomberg the payouts would average about $11,000

per litigant. An attorney familiar with the case and the

mediation said that a return to court-ordered mediation would

not necessarily improve the chances that the parties would

settle at that umber.

>

>

>

>

> Seroquel Maker Given More Time to Settle Lawsuits

>

>

>

> September 14, 2010. By Gordon Gibb

> /

> London, UK/: AstraZeneca, the manufacturer of /Seroquel/

>

<http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>,

> has been granted more time to settle nearly 6,000 lawsuits.

The lawsuits

> at issue are only a portion of some 17,500 lawsuits that

the

> manufacturer has agreed to settle by way of a $198 million

kitty. That

> announcement was made last month.

>

> However, the 6,000 will have to wait a little longer after

the US

> Judicial Panel on Multidistrict Litigation vacated orders

to send the

> cases back to their home courts for trial in late August.

The cases,

> consolidated in federal court in Florida, according to

/Bloomberg

> BusinessWeek/ on 10/01/10, could suffer undue hindrance in

arriving at

> settlements.

>

> "A remand at this juncture would likely disrupt the

settlement dialog,"

> US District Judge Anne Conway, based in Orlando, Florida,

said in an

> August 30 order asking the judicial panel to forgo remands.

Returning

> the cases could "stall negotiations altogether," Conway

said.

>

> AstraZeneca, the UK's second-largest drug manufacturer,

faces a total of

> 26,000 lawsuits alleging various Seroquel side effects,

including birth

> defects. The manufacturer has settled about two thirds of

those cases.

>

> "We remain committed to a strong defense effort, but will

continue to

> participate in the court-ordered mediation process," Tony

Jewell, a US

> spokesman for the drug maker, said in an interview on

August 31.

>

> According to /Bloomberg/ the payouts would average about

$11,000 per

> litigant. An attorney familiar wit! h the case and the

mediation said that

> a return to court-ordered mediation would not necessarily

improve the

> chances that the parties would settle at that umber. He

said that while

> he would continue to participate in the mediation process,

he believes

> that at that figure the cases would not settle.

>

> Seroquel, which has also been allegedly linked to

hyperglycemia and

> tardive dyskinesia, is the second-largest selling drug in

AstraZeneca's

> basket of products, achieving $4.9 billion in sales last

year, according

> to /Bloomberg/.

>

[Guest guest]

Can you post a link for that please? Thanks!

On 9/17/2010 2:34 PM, jeremy9282 wrote:

According to Bloomberg the payouts would average about $11,000

per litigant. An attorney familiar with the case and the

mediation said that a return to court-ordered mediation would

not necessarily improve the chances that the parties would

settle at that umber.

>

>

>

>

> Seroquel Maker Given More Time to Settle Lawsuits

>

>

>

> September 14, 2010. By Gordon Gibb

> /

> London, UK/: AstraZeneca, the manufacturer of /Seroquel/

>

<http://www.lawyersandsettlements.com/case/seroquel.html?ref=article14977>,

> has been granted more time to settle nearly 6,000 lawsuits.

The lawsuits

> at issue are only a portion of some 17,500 lawsuits that

the

> manufacturer has agreed to settle by way of a $198 million

kitty. That

> announcement was made last month.

>

> However, the 6,000 will have to wait a little longer after

the US

> Judicial Panel on Multidistrict Litigation vacated orders

to send the

> cases back to their home courts for trial in late August.

The cases,

> consolidated in federal court in Florida, according to

/Bloomberg

> BusinessWeek/ on 10/01/10, could suffer undue hindrance in

arriving at

> settlements.

>

> "A remand at this juncture would likely disrupt the

settlement dialog,"

> US District Judge Anne Conway, based in Orlando, Florida,

said in an

> August 30 order asking the judicial panel to forgo remands.

Returning

> the cases could "stall negotiations altogether," Conway

said.

>

> AstraZeneca, the UK's second-largest drug manufacturer,

faces a total of

> 26,000 lawsuits alleging various Seroquel side effects,

including birth

> defects. The manufacturer has settled about two thirds of

those cases.

>

> "We remain committed to a strong defense effort, but will

continue to

> participate in the court-ordered mediation process," Tony

Jewell, a US

> spokesman for the drug maker, said in an interview on

August 31.

>

> According to /Bloomberg/ the payouts would average about

$11,000 per

> litigant. An attorney familiar wit! h the case and the

mediation said that

> a return to court-ordered mediation would not necessarily

improve the

> chances that the parties would settle at that umber. He

said that while

> he would continue to participate in the mediation process,

he believes

> that at that figure the cases would not settle.

>

> Seroquel, which has also been allegedly linked to

hyperglycemia and

> tardive dyskinesia, is the second-largest selling drug in

AstraZeneca's

> basket of products, achieving $4.9 billion in sales last

year, according

> to /Bloomberg/.

>